ADMA Biologics, Inc. (ADMA)
13.24
+0.05
(+0.38%)
USD |
NASDAQ |
Nov 12, 16:00
13.45
+0.21
(+1.59%)
After-Hours: 20:00
ADMA Biologics Max Drawdown (5Y) : 82.48% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 82.48% |
| September 30, 2026 | 84.09% |
| August 31, 2026 | 84.37% |
| July 31, 2026 | 84.37% |
| June 30, 2026 | 84.37% |
| May 31, 2026 | 84.37% |
| April 30, 2026 | 84.37% |
| March 31, 2026 | 84.37% |
| February 28, 2026 | 84.37% |
| January 31, 2026 | 84.37% |
| December 31, 2025 | 84.37% |
| November 30, 2025 | 84.37% |
| October 31, 2025 | 84.37% |
| September 30, 2025 | 84.37% |
| August 31, 2025 | 84.37% |
| July 31, 2025 | 84.37% |
| June 30, 2025 | 84.37% |
| May 31, 2025 | 84.37% |
| April 30, 2025 | 84.37% |
| March 31, 2025 | 84.37% |
| February 28, 2025 | 84.77% |
| January 31, 2025 | 84.77% |
| December 31, 2024 | 84.77% |
| November 30, 2024 | 84.77% |
| October 31, 2024 | 84.77% |
| Date | Value |
|---|---|
| September 30, 2024 | 84.77% |
| August 31, 2024 | 84.77% |
| July 31, 2024 | 84.77% |
| June 30, 2024 | 84.77% |
| May 31, 2024 | 84.77% |
| April 30, 2024 | 84.77% |
| March 31, 2024 | 84.77% |
| February 29, 2024 | 84.77% |
| January 31, 2024 | 84.77% |
| December 31, 2023 | 84.77% |
| November 30, 2023 | 84.77% |
| October 31, 2023 | 84.77% |
| September 30, 2023 | 84.77% |
| August 31, 2023 | 84.77% |
| July 31, 2023 | 84.77% |
| June 30, 2023 | 84.77% |
| May 31, 2023 | 84.77% |
| April 30, 2023 | 84.77% |
| March 31, 2023 | 84.77% |
| February 28, 2023 | 84.77% |
| January 31, 2023 | 84.77% |
| December 31, 2022 | 84.77% |
| November 30, 2022 | 84.77% |
| October 31, 2022 | 84.77% |
| September 30, 2022 | 84.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 77.18% |
| BioMarin Pharmaceutical, Inc. | 58.73% |
| Nektar Therapeutics | 99.39% |
| Rhythm Pharmaceuticals, Inc. | 92.10% |
| Arcutis Biotherapeutics, Inc. | 95.02% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 45.42 |
| Beta (5Y) | 0.6546 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 54.63% |
| Historical Sharpe Ratio (5Y) | 0.9298 |
| Historical Sortino (5Y) | 1.839 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.65% |